Home Tags Pharmaceuticals

Tag: Pharmaceuticals

A startup with ties to Bayer has inked a $122 million deal to make lab-grown marijuana — and it’s eyeing the pharma industry

Boston-based startup Ginkgo Bioworks will use Cronos' labs to produce synthetic marijuana compounds, many of which "have the potential to be valuable in a range of pharmaceutical applications."

Stanford researchers are figuring out how ketamine fights depression — and why the drug has been called ‘the most important discovery in h...

A new Stanford study is the first to illuminate how ketamine works in the brain to alleviate depression. The research suggests that the drug engages the opioid system — the same one that's activated by opioid painkillers — in addition to affecting the glutamate system.

The strange history of the EpiPen, the device developed by the military that turned into a billion-dollar business and now faces generic competition b...

Here's the story of how a common, lifesaving device became a controversial drug-pricing story, facing recalls, shortages, and now generic competition between Mylan and Teva.

The drug maker behind the first FDA-approved medication derived from marijuana has revealed how much it’ll cost

On a call with investors this week, GW Pharmaceuticals revealed the price of Epidiolex, its newly-approved, marijuana-based drug for rare forms of epilepsy.

DNA-testing company 23andMe has signed a $300 million deal with a drug giant. Here’s how to delete your data if that freaks you out.

Genetics-testing companies like Ancestry and 23andMe can — and frequently do — sell your data to drugmakers. A $300 million deal between 23andMe and the pharmaceutical giant GlaxoSmithKline is the latest example. If that has you thinking about how these companies use your data, here's how to delete it.

Doctors are calling out a new drug that helps people with addiction for costing more than $1,700 a week — while a generic costs just $1

Two months after it became the first federally approved drug of its kind to treat addiction, doctors are calling out Lucemyra, a new branded medication to treat opioid withdrawal, for costing $1,737 more per week than a similar generic drug.

A pharma CEO says a new depression drug could have lasting effects after one short course, like antibiotics — here’s what experts think

Sage Therapeutics CEO Jeff Jonas said the new drug could help depressed people feel well "with just a two week course of treatment — similar to how antibiotics are used." No existing drug works that way, and this one hasn't yet been studied beyond a limited time frame when most drugs fail.

A drug derived from marijuana has become the first to win federal approval, and experts predict an avalanche effect

GW Pharmaceutical's drug Epidiolex just became the first marijuana-based drug to win FDA approval. Studies suggest its active ingredient, CBD, reduces seizures in two rare types of epilepsy. The approval will likely galvanize future marijuana research.

A ‘breakthrough’ depression drug inspired by ketamine is attracting more attention from big pharma

After 35 years of mediocre depression drugs, pharmaceutical companies are jazzed about several new drugs inspired by the club drug ketamine. Allergan, the multinational drugmaker known for Botox, recently dove into research on an injectable depression drug. Now they're going after an oral pill.

A drug derived from marijuana just got a big lift that will likely make it the first of its kind to get federal approval

A drug derived from marijuana to treat epilepsy is on the brink of winning US government approval. In its third large clinical trial, Epidiolex appeared to significantly reduce the worst symptoms of two severe forms of childhood epilepsy.